Back to Authors

Marrero Rolon, Rebecca

Mayo Clinic

Division of Clinical Microbiology, Mayo Clinic, Rochester, Minnesota, USA.

Citations 2

Erratum for Marrero Rolon et al., “Clinical Evaluation of a Real-Time PCR Assay for Simultaneous Detection of Helicobacter pylori and Genotypic Markers of Clarithromycin Resistance Directly from Stool”
Rolón, Rebecca Marrero, Mandrekar, Jayawant N. , Polo, Erin T., Patel, Robin , Marrero Rolon, Rebecca, Patel, Robin , Cunningham, Scott A.

Journal of Clinical Microbiology | February 16, 2022 | Volume: 60 | Issue: 2 | Pages: No page available

10.1128/jcm.02452-21 Get It

Clinical Evaluation of a Real-Time PCR Assay for Simultaneous Detection of Helicobacter pylori and Genotypic Markers of Clarithromycin Resistance Directly from Stool
Rolón, Rebecca Marrero, Cunningham, Scott A. , Mandrekar, Jayawant N. , Polo, Erin T., Patel, Robin , Marrero Rolon, Rebecca, Patel, Robin , Cunningham, Scott A

Journal of Clinical Microbiology | February 4, 2021 | Volume: 59 | Issue: 5 | Pages: No page available

10.1128/jcm.03040-20 Get It

Helicobacter pylori infection is mainly diagnosed noninvasively, with susceptibility testing traditionally requiring endoscopy. Treatment is empirical, with clarithromycin-based triple therapy recommended where resistance rates are below 15%. Rising rates of clarithromycin resistance, resulting in high therapy failure rates, are seen worldwide, but U.S. data are limited.